Signature Therapeutics, Inc.

Signature Therapeutics, Inc. (formerly PharmacoFore) is a privately-held biopharmaceutical company focused on creating novel medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications. They have developed a resilient business model for creating long-term value by pursuing a portfolio of carefully chosen programs where in drug activity is based upon known mechanisms-of-action and where human proof-of-concept can be achieved early in clinical trials. Their initial focus is on medicines for the central nervous system (CNS).